AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ANATARA LIFESCIENCES LTD

0.011

0.000

Volume:- -

Turnover:- -

Market Cap:3.45M

PE:-1.15

High:0.011

Open:0.011

Low:0.011

Close:0.011

52wk High:0.059

52wk Low:0.004

Shares:313.59M

Float Shares:125.36M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.010

EPS(LYR):-0.010

ROE:-205.70%

ROA:-86.74%

PB:6.44

PE(LYR):-1.15

Loading ...

Overview Company News Filings

Concept

Pharmaceutical Companies+1.74%

Capital Flow

Inflow:

Outflow:

News

Anatara Lifesciences Ltd-Chair's Address to Shareholders

THOMSON REUTERS

Here's Why We Think Anatara Lifesciences Ltd's (ASX:ANR) CEO Compensation Looks Fair

Simply Wall St.

BUZZ-Australia's Anatara Lifesciences falls on discounted placement

BRIEF-Anatara Lifesciences Receives Firm Commitments For A$1.2M Placement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ANR.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ANR.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ANR.AU\",,,,,undefined,":{"symbol":"ANR.AU","market":"AU","secType":"STK","nameCN":"ANATARA LIFESCIENCES LTD","latestPrice":0.011,"timestamp":1770700320000,"preClose":0.011,"halted":0,"volume":0,"delay":0,"changeRate":0,"nameEN":"ANATARA LIFESCIENCES LTD","floatShares":125359802,"shares":313590339,"eps":-0.009549,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-10 16:12:00 AEDT","open":0.011,"high":0.011,"low":0.011,"amount":0,"amplitude":0,"askPrice":0.012,"askSize":108936,"bidPrice":0.011,"bidSize":50000,"shortable":3,"etf":0,"ttmEps":-0.009549,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.011,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ANR.AU\",,,,,undefined,":{"symbol":"ANR.AU","floatShares":125359802,"roa":"-86.74%","roe":"-205.70%","lyrEps":-0.009549,"shares":313590339,"dividePrice":0,"high":0.011,"amplitude":0,"preClose":0.011,"low":0.011,"week52Low":0.004,"pbRate":"6.44","psRate":"3.56","week52High":0.059,"institutionHeld":0,"latestPrice":0.011,"committee":-0.370816,"eps":-0.009549,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.009549,"open":0.011,"prevYearClose":0.014,"prevWeekClose":0.01,"prevMonthClose":0.012,"prevQuarterClose":0.014,"fiveDayClose":0.012,"twentyDayClose":0.013,"sixtyDayClose":0.013,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ANR.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ANR.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ANR.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584971917","title":"Anatara Lifesciences Ltd-Chair's Address to Shareholders","url":"https://stock-news.laohu8.com/highlight/detail?id=2584971917","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584971917?lang=en_us&edition=fundamental","pubTime":"2025-11-20 06:44","pubTimestamp":1763592274,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nTUE6BGWJG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","ANR.AU"],"gpt_icon":0},{"id":"2583545726","title":"Here's Why We Think Anatara Lifesciences Ltd's (ASX:ANR) CEO Compensation Looks Fair","url":"https://stock-news.laohu8.com/highlight/detail?id=2583545726","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583545726?lang=en_us&edition=fundamental","pubTime":"2025-11-14 04:47","pubTimestamp":1763066863,"startTime":"0","endTime":"0","summary":"Key Insights Anatara Lifesciences will host its Annual General Meeting on 20th of November CEO David Brookes' total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-anr/anatara-lifesciences-shares/news/heres-why-we-think-anatara-lifesciences-ltds-asxanr-ceo-comp","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-anr/anatara-lifesciences-shares/news/heres-why-we-think-anatara-lifesciences-ltds-asxanr-ceo-comp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7508","ANR.AU","BK7067"],"gpt_icon":0},{"id":"2572597302","title":"BUZZ-Australia's Anatara Lifesciences falls on discounted placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2572597302","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572597302?lang=en_us&edition=fundamental","pubTime":"2025-10-01 11:13","pubTimestamp":1759288430,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Anatara Lifesciences falls on discounted placement** Shares of Anatara Lifesciences ANR.AX fall as much as 6.3% to A$0.015, their lowest since September 22** Shares post biggest intraday pct fall since September 19** Gastrointestinal health products maker receives firm commitments for A$1.2 million  placement** Issue price of A$0.012 represents a discount of 25% to stock's last close** Proceeds to be used to fund ANR's current anti-obesity project and due diligence on other opportunities and assets** Stock down 68.1% YTD, including session's moves  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nL6N3VI05C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","ANR.AU","BK7508"],"gpt_icon":0},{"id":"2572309900","title":"BRIEF-Anatara Lifesciences Receives Firm Commitments For A$1.2M Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2572309900","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572309900?lang=en_us&edition=fundamental","pubTime":"2025-10-01 09:24","pubTimestamp":1759281870,"startTime":"0","endTime":"0","summary":"BRIEF-Anatara Lifesciences Receives Firm Commitments For A$1.2M Placement Oct 1 (Reuters) - Anatara Lifesciences Ltd ANR.AX:RECEIVES FIRM COMMITMENTS FOR A$1.2M PLACEMENT AT A$0.012/SHAREFurther company coverage: ANR.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251001:nFWN3VH10X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","ANR.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":3,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ANR.AU\",params:#limit:6,delay:true,,,undefined,":[{"market":"AU","name":"Pharmaceutical Companies","bkCode":"BK7508","id":"package_au_concept_yyswg","changeRate":0.017447}]}}